1	Cell-specific	cell-specific	_	_	_	_	_	_	_
2	differences	difference	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	NF-kappa	NF-kappa	_	_	_	_	_	_	_
7	B	B	_	_	_	_	_	_	_
8	regulatory	regulatory	_	_	_	_	_	_	_
9	elements	element	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
13	virus	virus	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	beta	beta	_	_	_	_	_	_	_
16	interferon	interferon	_	_	_	_	_	_	_
17	promoters	promoter	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	tumor	tumor	_	_	_	_	_	_	_
20	necrosis	necrosis	_	_	_	_	_	_	_
21	factor	factor	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Three	three	_	_	_	_	_	_	_
2	aspects	aspect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	involvement	involvement	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	tumor	tumor	_	_	_	_	_	_	_
8	necrosis	necrosis	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	human	human	_	_	_	_	_	_	_
12	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
13	virus	virus	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	HIV	HIV	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	pathogenesis	pathogenesis	_	_	_	_	_	_	_
18	were	be	_	_	_	_	_	_	_
19	examined.	examined.	_	_	_	_	_	_	_
20	Tumor	tumor	_	_	_	_	_	_	_
21	necrosis	necrosis	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	mRNA	mrna	_	_	_	_	_	_	_
28	production	production	_	_	_	_	_	_	_
29	was	be	_	_	_	_	_	_	_
30	analyzed	analyze	_	_	_	_	_	_	_
31	by	by	_	_	_	_	_	_	_
32	polymerase	polymerase	_	_	_	_	_	_	_
33	chain	chain	_	_	_	_	_	_	_
34	reaction	reaction	_	_	_	_	_	_	_
35	amplification	amplification	_	_	_	_	_	_	_
36	in	in	_	_	_	_	_	_	_
37	monocytic	monocytic	_	_	_	_	_	_	_
38	U937	u937	_	_	_	_	_	_	_
39	cells	cell	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	in	in	_	_	_	_	_	_	_
42	a	a	_	_	_	_	_	_	_
43	chronically	chronically	_	_	_	_	_	_	_
44	HIV	HIV	_	_	_	_	_	_	_
45	infected	infected	_	_	_	_	_	_	_
46	U937	u937	_	_	_	_	_	_	_
47	cell	cell	_	_	_	_	_	_	_
48	line	line	_	_	_	_	_	_	_
49	(	(	_	_	_	_	_	_	_
50	U9-IIIB	U9-IIIB	_	_	_	_	_	_	_
51	)	)	_	_	_	_	_	_	_
52	.	.	_	_	_	_	_	_	_

1	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
2	RNA	RNA	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	undetectable	undetectable	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	U937	u937	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	whereas	whereas	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	low	low	_	_	_	_	_	_	_
12	constitutive	constitutive	_	_	_	_	_	_	_
13	level	level	_	_	_	_	_	_	_
14	was	be	_	_	_	_	_	_	_
15	detected	detect	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	U9-IIIB	U9-IIIB	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Paramyxovirus	Paramyxovirus	_	_	_	_	_	_	_
2	infection	infection	_	_	_	_	_	_	_
3	induced	induce	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	5-	5-	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	10-fold	10-fold	_	_	_	_	_	_	_
8	increase	increase	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	steady-state	steady-state	_	_	_	_	_	_	_
12	level	level	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
15	RNA	RNA	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	U9-IIIB	U9-IIIB	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	compared	compare	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	U937	u937	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	suggesting	suggest	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	HIV-infected	hiv-infected	_	_	_	_	_	_	_
27	monocytic	monocytic	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	produced	produce	_	_	_	_	_	_	_
30	higher	high	_	_	_	_	_	_	_
31	levels	level	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
34	than	than	_	_	_	_	_	_	_
35	did	do	_	_	_	_	_	_	_
36	normal	normal	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	after	after	_	_	_	_	_	_	_
39	a	a	_	_	_	_	_	_	_
40	secondary	secondary	_	_	_	_	_	_	_
41	virus	virus	_	_	_	_	_	_	_
42	infection	infection	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
5	on	on	_	_	_	_	_	_	_
6	gene	gene	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	examined	examine	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	transient	transient	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	assays	assay	_	_	_	_	_	_	_
14	using	use	_	_	_	_	_	_	_
15	reporter	reporter	_	_	_	_	_	_	_
16	chloramphenicol	chloramphenicol	_	_	_	_	_	_	_
17	acetyltransferase	acetyltransferase	_	_	_	_	_	_	_
18	plasmids	plasmid	_	_	_	_	_	_	_
19	linked	link	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	regulatory	regulatory	_	_	_	_	_	_	_
22	elements	element	_	_	_	_	_	_	_
23	from	from	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	HIV	HIV	_	_	_	_	_	_	_
26	long	long	_	_	_	_	_	_	_
27	terminal	terminal	_	_	_	_	_	_	_
28	repeat	repeat	_	_	_	_	_	_	_
29	(	(	_	_	_	_	_	_	_
30	LTR	LTR	_	_	_	_	_	_	_
31	)	)	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	beta	beta	_	_	_	_	_	_	_
35	interferon	interferon	_	_	_	_	_	_	_
36	promoter	promoter	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	U937	U937	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	Jurkat	Jurkat	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	lymphoid	lymphoid	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	inducibility	inducibility	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	different	different	_	_	_	_	_	_	_
14	hybrid	hybrid	_	_	_	_	_	_	_
15	promoters	promoter	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
18	or	or	_	_	_	_	_	_	_
19	phorbol	phorbol	_	_	_	_	_	_	_
20	ester	ester	_	_	_	_	_	_	_
21	varied	vary	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	type-	type-	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	promoter	promoter	_	_	_	_	_	_	_
28	context-specific	context-specific	_	_	_	_	_	_	_
29	manner	manner	_	_	_	_	_	_	_
30	;	;	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	levels	level	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	gene	gene	_	_	_	_	_	_	_
35	activity	activity	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	NF-kappa	NF-kappa	_	_	_	_	_	_	_
38	B-containing	b-containing	_	_	_	_	_	_	_
39	plasmids	plasmid	_	_	_	_	_	_	_
40	correlated	correlate	_	_	_	_	_	_	_
41	directly	directly	_	_	_	_	_	_	_
42	with	with	_	_	_	_	_	_	_
43	induction	induction	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	NF-kappa	NF-kappa	_	_	_	_	_	_	_
46	B	B	_	_	_	_	_	_	_
47	DNA-binding	dna-binding	_	_	_	_	_	_	_
48	activity	activity	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	intact	intact	_	_	_	_	_	_	_
4	beta	beta	_	_	_	_	_	_	_
5	interferon	interferon	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	only	only	_	_	_	_	_	_	_
9	weakly	weakly	_	_	_	_	_	_	_
10	stimulated	stimulate	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	phorbol	phorbol	_	_	_	_	_	_	_
13	ester	ester	_	_	_	_	_	_	_
14	or	or	_	_	_	_	_	_	_
15	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	multimers	multimer	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	PRDII	PRDII	_	_	_	_	_	_	_
21	NF-kappa	NF-kappa	_	_	_	_	_	_	_
22	B-binding	b-binding	_	_	_	_	_	_	_
23	domain	domain	_	_	_	_	_	_	_
24	were	be	_	_	_	_	_	_	_
25	inducible	inducible	_	_	_	_	_	_	_
26	by	by	_	_	_	_	_	_	_
27	both	both	_	_	_	_	_	_	_
28	agents	agent	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
2	was	be	_	_	_	_	_	_	_
3	able	able	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	increase	increase	_	_	_	_	_	_	_
6	expression	expression	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	HIV	HIV	_	_	_	_	_	_	_
10	LTR	LTR	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	monocytic	monocytic	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
21	did	do	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	induce	induce	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	HIV	HIV	_	_	_	_	_	_	_
26	LTR	LTR	_	_	_	_	_	_	_
27	above	above	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	constitutive	constitutive	_	_	_	_	_	_	_
30	level	level	_	_	_	_	_	_	_
31	of	of	_	_	_	_	_	_	_
32	activity	activity	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	level	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B-independent	b-independent	_	_	_	_	_	_	_
6	activity	activity	_	_	_	_	_	_	_
7	appears	appear	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	be	be	_	_	_	_	_	_	_
10	sufficient	sufficient	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	virus	virus	_	_	_	_	_	_	_
13	multiplication	multiplication	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	since	since	_	_	_	_	_	_	_
16	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
17	treatment	treatment	_	_	_	_	_	_	_
18	had	have	_	_	_	_	_	_	_
19	no	no	_	_	_	_	_	_	_
20	effect	effect	_	_	_	_	_	_	_
21	on	on	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	kinetics	kinetic	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	de	de	_	_	_	_	_	_	_
26	novo	novo	_	_	_	_	_	_	_
27	HIV	HIV	_	_	_	_	_	_	_
28	type	type	_	_	_	_	_	_	_
29	1	1	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	HIV-1	HIV-1	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	infection	infection	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	viral	viral	_	_	_	_	_	_	_
36	RNA	RNA	_	_	_	_	_	_	_
37	production	production	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	U937	u937	_	_	_	_	_	_	_
40	cells	cell	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	Jurkat	Jurkat	_	_	_	_	_	_	_
5	cells	cell	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
8	dramatically	dramatically	_	_	_	_	_	_	_
9	enhanced	enhance	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	spread	spread	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	HIV-1	HIV-1	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	population	population	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	increased	increase	_	_	_	_	_	_	_
20	viral	viral	_	_	_	_	_	_	_
21	RNA	RNA	_	_	_	_	_	_	_
22	synthesis	synthesis	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	indicating	indicate	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	T	t	_	_	_	_	_	_	_
28	cells	cell	_	_	_	_	_	_	_
29	HIV-1	HIV-1	_	_	_	_	_	_	_
30	multiplication	multiplication	_	_	_	_	_	_	_
31	was	be	_	_	_	_	_	_	_
32	stimulated	stimulate	_	_	_	_	_	_	_
33	by	by	_	_	_	_	_	_	_
34	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
35	treatment	treatment	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

